It was an excellent day for Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) with a 37.81 percent increase in its share prices closing at $8.93. Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) announced that the biopharmaceutical has received fast track designation for its NASH treatment drug, Aramchol, from the FDA. Fast Track Designation is given to the drugs developed for the…